CLINICAL_TRIALS
trial_result
· 2022-04-12
Clinical Trial Update: Pulmonary Rehab in Chronic Obstructive Pulmonary Disease (COPD): Response to Tyvaso [Phase 2]
Summary
Phase 2 trial update on pulmonary rehabilitation in COPD; study terminated with results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Inova Health Care Services | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | Status: TERMINATED | Results posted: 2022-04-12